Department of Microbiology & Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, Dental Sciences Building, Rm 3014, London, Ontario, N6A 5C1, Canada; Matthew Mailing Centre for Translational Transplant Studies, University Hospital, London Health Sciences Centre, 339 Windemere Road, London, Ontario, N6A 5A5, Canada.
Exeter Medical School, Medical School Building G10, St. Luke's Campus, Magdalene Road, Exeter, EX1 2LU, United Kingdom.
Nitric Oxide. 2018 Dec 1;81:57-66. doi: 10.1016/j.niox.2018.10.004. Epub 2018 Oct 25.
Renal transplantation is the preferred treatment for end-stage renal disease. Currently, there is a large gap between the supply and demand for transplantable kidneys. The use of sub-optimal grafts obtained via donation after cardiac death (DCD) is on the rise. While static cold storage (SCS) in University of Wisconsin (UW) solution on ice (4°C) is the clinical standard of care for renal graft preservation, cold storage has been associated with negative graft outcomes. The alternative, normothermic machine perfusion, involves mechanical perfusion of the organ at physiological or normothermic temperature (37°C) and this technique is expensive, complicated and globally inaccessible. As such, simpler alternatives are of interest. Preliminary results revealed that UW solution is more protective at 21°C than 37°C and subnormothermic preservation is of interest because it may facilitate the use of existing solutions while preventing cold injury. We have previously shown that SCS in UW solution supplemented with mitochondria-targeted HS donor AP39 improves renal graft outcomes. As such, it was hypothesized subnormothermic preservation at 21°C with AP39 will also improve renal outcomes. Using an in vitro model of hypoxia and reoxygenation, we found that treating porcine tubular epithelial cells with UW+5 μM AP39 during 18 h hypoxia at 21°C significantly increased renal tubular epithelial cell viability after 24 h of reoxygenation at 37°C compared to UW alone. Also, AP39-supplemented UW solution was significantly more cytoprotective during hypoxia at 21°C than hypoxia at 37°C, regardless of AP39 concentration. Using an ex vivo DCD organ preservation model, we found that DCD porcine kidneys stored for 24 h in UW+200 nM AP39 at 21°C showed significantly lower tissue necrosis than DCD porcine kidneys preserved using SCS in UW solution, the clinical standard of care. Overall, our findings suggest that exogenous HS supplementation improves the viability of the gold standard organ preservation solution, UW solution, for subnormothermic preservation at 21°C.
肾移植是治疗终末期肾病的首选方法。目前,可移植肾脏的供需之间存在巨大差距。使用通过心脏死亡后捐献(DCD)获得的次优移植物的情况正在增加。虽然在威斯康星大学(UW)溶液中在冰上(4°C)进行静态冷保存(SCS)是肾移植物保存的临床标准护理,但冷保存与移植物不良结局有关。替代方法,即常温机械灌注,涉及在生理或常温(37°C)下对器官进行机械灌注,该技术昂贵、复杂且在全球范围内无法获得。因此,简单的替代方法很有意义。初步结果表明,UW 溶液在 21°C 时比在 37°C 时更具保护作用,亚常温保存很有意义,因为它可以在防止冷损伤的同时促进现有溶液的使用。我们之前已经表明,UW 溶液中添加线粒体靶向 HS 供体 AP39 的 SCS 可改善肾移植物的结局。因此,假设在 21°C 下使用 AP39 进行亚常温保存也将改善肾结局。使用缺氧和再氧合的体外模型,我们发现,在 21°C 下缺氧 18 小时期间用 UW+5μM AP39 处理猪肾小管上皮细胞,与仅用 UW 相比,在 37°C 下再氧合 24 小时后,肾小管上皮细胞活力显著增加。此外,在 21°C 下缺氧时,添加 AP39 的 UW 溶液比在 37°C 下缺氧时具有更高的细胞保护作用,而与 AP39 浓度无关。使用离体 DCD 器官保存模型,我们发现,在 21°C 下用 UW+200nM AP39 保存 24 小时的 DCD 猪肾比使用 UW 溶液的临床标准护理保存的 DCD 猪肾显示出明显较低的组织坏死。总的来说,我们的研究结果表明,外源性 HS 补充剂可提高 UW 溶液等金标准器官保存溶液在 21°C 下亚常温保存的活力。